Vitamin D deficiency in pregnancy and gestational diabetes mellitus




Objective


We examined the association of second-trimester maternal plasma 25-hydroxyvitamin D (25[OH]D) during pregnancy with gestational diabetes mellitus (GDM).


Study Design


Among 1314 pregnant women who participated in Project Viva, a birth cohort study, we measured 25(OH)D levels at 26-28 weeks gestation during GDM screening using a 1-hour 50-g glucose challenge test.


Results


We found 25(OH)D levels of <25 nmol/L in 44 of 1087 women (4.0%) with normal glucose tolerance, 9 of 159 women (5.7%) with impaired glucose tolerance, and 9 of 68 women (13.2%) with GDM. Analyses that were adjusted for sociodemographics, season, maternal body mass index, gestational weight gain, and dietary factors suggested that women with 25(OH)D levels of <25 vs ≥25 nmol/L may have higher odds of experiencing GDM (odds ratio, 2.2; 95% confidence interval, 0.8–5.5). Glucose levels after the glucose challenge test were associated inversely with 25(OH)D levels ( P < .01).


Conclusion


Second-trimester 25(OH)D levels were associated inversely with glucose levels after 1-hour 50-g glucose challenge test; low 25(OH)D levels may be associated with increased risk of GDM.


Gestational diabetes mellitus (GDM) and impaired glucose intolerance (IGT) affect maternal, fetal, and neonatal well-being. GDM complicates 14% of pregnancies in the United States, and its incidence is rising. In mothers, GDM is associated with higher risk of cesarean section delivery and the later development of type 2 diabetes mellitus. For offspring, GDM is associated with macrosomia, birth trauma, respiratory distress syndrome, jaundice, and hypoglycemia. The causes of GDM and IGT are an active area of investigation, with growing interest in vitamin D deficiency as a potential cause. Although epidemiologic studies have shown a fairly consistent link between vitamin D deficiency and a higher risk of type 2 diabetes mellitus and although obesity is associated strongly with both GDM and vitamin D deficiency, it remains unclear whether vitamin D status affects a mother’s risk of experiencing GDM.




See Journal Club, page 235



A few studies support an association between low 25-hydroxyvitamin D (25[OH]D) levels and an increased risk of GDM, but a recent prospective study found no evidence of an association between first-trimester 25(OH)D levels and the subsequent development of GDM. Another study did not find an association between 25(OH)D level and GDM but did report an inverse relationship between 25(OH)D level and glucose concentrations 30 minutes after a 100-g glucose load. These studies have various limitations that include a lack of adjustment for maternal body mass index, a low incidence of obesity, and a lack of generalizability to US and other Western populations and no adjustment for dietary factors or physical activity. Physical activity could be an important confounder of the relationship between GDM and 25(OH)D because active women are less likely to have IGT and may be more likely to have higher 25(OH)D levels than more sedentary women because of increased sunlight exposure.


To study the relationship between vitamin D status during pregnancy and GDM, we analyzed data from a prospective prenatal cohort of >1300 mother-infant pairs. We hypothesized that lower 25(OH)D levels would be associated with increased odds of GDM and higher glucose concentrations. We also hypothesized that maternal physical activity would account for part of the association between lower 25(OH)D level and higher risk of GDM and that adjustment for this factor would attenuate the observed association.


Materials and Methods


We studied participants from Project Viva, a prospective prenatal cohort study of gestational factors and offspring health. We recruited women who attended their initial prenatal visit at 8 obstetrics offices of a multispecialty group practice in Massachusetts. Eligibility criteria included maternal fluency in English, singleton pregnancy, and gestational age <22 weeks. Details of cohort recruitment and retention processes have been published previously. Participants provided written informed consent. Institutional review boards of participating institutions approved the study.


Of the 2128 participants who gave birth, 1314 mothers had both second-trimester 25(OH)D levels and GDM status information. Cohort participants who were included in this analysis were similar to those who were excluded except that they were more likely to have graduated from college (68% vs 59%), were slightly older (mean age, 32 vs 31 years), and were slightly less likely to have GDM (5.2% vs 6.4%).


Measurement of vitamin D status


We measured 25(OH)D levels, a combination of 25(OH)D 2 and 25(OH)D 3 , in previously frozen maternal blood samples that were obtained during a routine nonfasting clinical blood draw at 26-28 weeks gestation. We refrigerated blood samples, centrifuged the samples, and stored plasma aliquots at –80°C. We measured 25(OH)D levels for each specimen twice, first with an automated chemiluminescence immunoassay and then with a manual radioimmunoassay. For quality control, the laboratory used US National Institute of Standards and Technology level 1. Because the singlicate 25(OH)D results from the 2 assays were not identical (r = 0.81), we averaged the 2 values for each specimen to obtain a more stable estimate of 25(OH)D level. In general, analyses that use either the chemiluminescence immunoassay data only or radioimmunoassay data only yielded similar results.


Ascertainment of GDM


We obtained data on GDM from the clinical record. Women underwent routine screening for GDM at 26-28 weeks’ gestation with a nonfasting oral glucose challenge test. If, 1 hour after a nonfasting 50-g oral glucose load, the glucose level was ≥140 mg/dL, the participant was referred for a 100-g fasting glucose 3-hour tolerance tests. Normal results were a fasting blood glucose level of <95 mg/dL at baseline, <180 mg/dL at 1 hours, <155 mg/dL at 2 hours, and <140 mg/dL at 3 hours. We categorized participants with a normal glucose screening as having normal glucose tolerance and participants who did not have a normal result after the screening as having IGT ( Figure 1 ). We classified women with at least 2 abnormal results on the fasting glucose tolerance test as having GDM.




FIGURE 1


Project Viva

Categorization of glucose tolerance based on 50-g, 1-hour, nonfasting glucose challenge test and subsequent fasting 100-g, 3-hour glucose tolerance test.

GDM , gestational diabetes mellitus; GTT , glucose tolerance test; IGT , impaired glucose tolerance.

Burris. Vitamin D and GDM. Am J Obstet Gynecol 2012.


Assessment of covariates


Through the interviews, study questionnaires, and medical record reviews, we collected information on self-designated maternal age, race/ethnicity, parity, smoking habits, education, marital status, and household income. We calculated gestational age in weeks at the time of the blood sample by subtracting the date of the last menstrual period from the date of the blood draw. Eighty-six percent of the participants had ultrasound data available at 16-20 weeks’ gestation. For approximately 12% of the ultrasound scans, gestational age estimates differed by >10 days from the last menstrual period pregnancy dating; for these, we used the dating that was obtained from the ultrasound scan. We calculated prepregnancy body mass index on the basis of self-reported prepregnancy height and weight. We calculated gestational weight gain at 20 weeks’ gestation by subtracting the self-reported prepregnancy weight from the weight measured at 20 weeks’ gestation. We defined physical activity as hours spent walking or time spent performing light-to-moderate or vigorous activities in the 3 months before the 26- to 28-week blood draw. We obtained dietary intake data (fish and micronutrient intake that included calcium and vitamin D) with a previously validated, semiquantitative food frequency questionnaire that was administered in the first and second trimesters of pregnancy. We adjusted micronutrient intake for energy intake using a residuals model.


Statistical analysis


We first performed bivariate analyses to determine maternal and infant characteristics that were associated with previously described clinical categories of vitamin D status : severe deficiency (<25 nmol/L), deficiency (25 to <50 nmol/L), insufficiency (50 to <75 nmol/L), and sufficiency (≥75 nmol/L). We further dichotomized 25(OH)D levels at 25 nmol/L because preliminary analyses of the odds of GDM demonstrated a threshold; compared with women with 25(OH)D levels <25 nmol/L, women with levels of 25 to <50, 50 to <75 and ≥75 had unadjusted odds ratios (ORs) for GDM of 0.25, 0.32, and 0.20, respectively. We used multivariable-adjusted multinomial logistic regression models to examine associations between severe vitamin D deficiency and the odds of the development of GDM or IGT compared with women with normal glucose tolerance. We excluded covariates that did not confound the relationship between 25(OH)D level and the odds of GDM.


To analyze the relationship between vitamin D status and blood glucose measurement after the 1-hour glucose challenge screening test, we conducted analyses that predicted glucose as a continuous variable using multivariate linear regression models. In these models, we used 25(OH)D status as a continuous independent variable and adjusted for the same covariates as the GDM analyses.


As is common in large epidemiologic studies, many covariates were missing on some subjects. We used chained equations to multiply impute values for these covariates. We generated 10 imputed datasets; all model results are generated by appropriately combining these results. To avoid incorrect imputations, all 2128 Project Viva subjects were used in the imputation process ; however, only those with observed 25(OH)D were included in the analysis. All analyses were performed in SAS software (version 9.3; SAS Institute Inc, Cary, NC).




Results


Second-trimester 25(OH)D levels


The mean (SE) 25(OH)D level was 59 ± 0.6 nmol/L. The levels were lower among women with higher body mass index, lower pregnancy weight gain, lower vitamin D intake, and lower calcium intake ( Table 1 ). Women with lower levels were more likely to have less than a college education, to be single, to be from households with <$70,000 annual income, and to be nonwhite. Counter to our expectations, physical activity appeared to be associated inversely with 25(OH)D level; women in the lowest category (<25 nmol/) reported 9.3 hours/week of physical activity vs 7.2 hours/week among women with 25(OH)D levels of ≥75 nmol/L. Younger women in our cohort reported more physical activity (Pearson correlation coefficient, –0.15; P < .001) and had lower 25(OH)D levels than older women (Pearson correlation coefficient, 0.15; P < .001). We do not have data on whether physical activity was indoor or outdoor.



TABLE 1

Characteristics of 1314 participants in Project Viva
































































































































Variable No imputation Complete data (n = 1314) Category of second-trimester 25-hydroxyvitamin D (nmol/L) a <25 (n = 62) 25 to <50 (n = 385) 50 to <75 (n = 620) ≥75 (n = 247)
n Mean SE Mean SE
Second-trimester 25(OH)D (nmol/L) 1314 59 0.6 59 0.6 20 39 62 90
Maternal age at enrollment (y) 1314 32 0.1 32 0.1 30 31 33 33
Prepregnancy body mass index (kg/m 2 ) 1308 24.7 0.1 24.7 0.1 28.6 25.8 24.1 23.7
Gestational age at blood draw (wk) 1314 28 0.04 28 0.04 28 28 28 28
Pregnancy weight gain to 20 weeks’ gestation (kg) 1302 5.9 0.1 5.9 0.1 4.8 5.7 6.2 5.5
Blood glucose level 1 hour after 50-g glucose load (mg/dL) 1307 114 0.7 114 0.7 122 116 114 111
Physical activity during pregnancy (hr/wk) 1096 6.9 0.2 7.1 0.2 9.3 7.5 6.6 7.2
Total vitamin D intake (IU/d) 1217 547 4.8 541 4.9 373 489 571 588
Total calcium intake (mg/d) 1217 1381 10.1 1371 10.1 1142 1250 1436 1455
Fish intake (servings/wk) 1217 1.6 0.04 1.6 0.04 1.8 1.5 1.5 1.6


































































































































































































































































































n % % % % % %
Education
Less than college graduate 420 32 32 66 39 28 22
College graduate 888 68 68 34 61 72 78
Marital status
Single 91 7 7 18 10 5 4
Married or cohabitating 1216 93 93 82 90 95 96
Smoking status
Never 863 68 68 76 66 68 68
Former 253 20 20 10 19 20 23
During pregnancy 158 12 12 14 15 12 9
Household income
≤$70,000/y 457 38 39 78 45 35 31
>$70,000/y 760 62 61 22 55 65 69
Parity
0 622 47 47 29 46 50 48
≥1 692 53 53 71 54 50 52
Race/ethnicity
White 943 72 72 22 61 79 85
Black 186 14 14 55 20 9 8
Hispanic 76 6 6 13 8 5 4
Other 103 8 8 10 11 8 4
Glucose tolerance
Gestational diabetes mellitus 68 5 5 15 4 5 4
Impaired glucose tolerance 159 12 12 15 15 11 9
Normal 1087 83 83 71 81 83 87

Burris. Vitamin D and GDM. Am J Obstet Gynecol 2012.

a Data are given as the mean or n as indicated.



GDM and IGT


Sixty-eight women(5.2%) met criteria for GDM. Unadjusted analysis revealed that women with 25(OH)D levels of <25 vs >25 nmol/L had significantly increased odds of GDM (OR, 3.6; 95% confidence interval [CI], 1.7–7.8; Table 2 ). Adjustment for race/ethnicity, age, education, marital status, smoking, parity, and season of blood draw made little difference to this estimate (OR, 3.1; 95% CI, 1.3–7.4). Additional adjustment for maternal body mass index attenuated the association; the confidence interval included the null value (OR, 2.2; 95% CI, 0.9–5.6). Further adjustment for pregnancy weight gain made little difference (OR, 2.3; 95% CI, 0.9–5.7). Addition of physical activity and dietary intakes of fish and calcium also made little difference (OR, 2.2; 95% CI, 0.8–5.5).



TABLE 2

Odds of gestational diabetes mellitus in subjects with severe vitamin D deficiency a , b
























25-hydroxyvitamin D exposure Odds ratio (95% CI)
Model 1 c Model 2 d Model 3 e Model 4 f
Gestational diabetes mellitus vs normal glucose tolerance 3.6 (1.7, 7.8) 3.1 (1.3, 7.4) 2.3 (0.9, 5.7) 2.2 (0.8, 5.5)
Impaired glucose tolerance vs normal glucose tolerance 1.4 (0.7, 3.0) 1.6 (0.7, 3.5) 1.4 (0.6, 3.2) 1.4 (0.6, 3.3)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 15, 2017 | Posted by in GYNECOLOGY | Comments Off on Vitamin D deficiency in pregnancy and gestational diabetes mellitus

Full access? Get Clinical Tree

Get Clinical Tree app for offline access